Dyslipidaemia

被引：278

作者：

Durrington, P ^{[1
]}

机构：

[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England

来源：

LANCET | 2003年 / 362卷 / 9385期

关键词：

D O I：

10.1016/S0140-6736(03)14234-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The lowering of serum cholesterol is increasingly recognised as essential in the prevention of coronary heart disease and other atherosclerotic disease. The success of statin trials and the need to deploy these drugs effectively in the population has led increasingly to the identification of many people whose serum cholesterol, triglycerides, and HDL-cholesterol require clinical assessment, and frequently treatment. Lipid disorders are mainly straightforward, but some are complex or resistant to simple treatment strategies. I have reviewed the clinical manifestations of disordered lipid metabolism (dysilpidaemia) and its management.

引用

页码：717 / 731

页数：15

共 157 条

[1] AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].

ANDERSON, KM ;

WILSON, PWF ;

ODELL, PM ;

KANNEL, WB .

CIRCULATION, 1991, 83 (01) :356-362

[2]

[Anonymous], 1991, BMJ, V303, P893

[3]

[Anonymous], 2002, JAMA

[4]

[Anonymous], 1995, FAMILIAL HYPERCHOLES

[5] Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH:: a clinical and molecular genetic analysis [J].

Arca, M ;

Zuliani, G ;

Wilund, K ;

Campagna, F ;

Fellin, R ;

Bertolini, S ;

Calandra, S ;

Ricci, G ;

Glorioso, N ;

Maioli, M ;

Pintus, P ;

Carru, C ;

Cossu, F ;

Cohen, J ;

Hobbs, HH .

LANCET, 2002, 359 (9309) :841-847

[6] RELATION OF HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL AND TRIGLYCERIDES TO INCIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE (THE PROCAM EXPERIENCE) [J].

ASSMANN, G ;

SCHULTE, H .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (07) :733-737

[7]

Assmann G, 1995, METABOLIC MOL BASES, P2053

[8] Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[9] Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study [J].

Austin, MA ;

McKnight, B ;

Edwards, KL ;

Bradley, CM ;

McNeely, MJ ;

Psaty, BM ;

Brunzell, JD ;

Motulsky, AC .

CIRCULATION, 2000, 101 (24) :2777-2782

[10] ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].

AUSTIN, MA ;

KING, MC ;

VRANIZAN, KM ;

KRAUSS, RM .

CIRCULATION, 1990, 82 (02) :495-506

← 1 2 3 4 5 6 7 8 9 10 →